- €43.63bn
- €77.10bn
- €45.58bn
Brief: Bayer AG Says Co To Consolidate U.S. Glyphosate Business Into Distinct Entity Operating As Ruveon
AlphaValue raises Bayer to 'add' as litigation risks ease
Europe Research Roundup: Bayer, Nexans, Wartsila
Bayer seeks US duties on Chinese-made glyphosate, angering farmers
Bayer's $7.25 billion Roundup settlement gets August hearing date
Focus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
Bayer takes a giant leap toward investability
Europe Research Roundup: Barratt Redrow, Ferrari, KPN
Explainer: What does Bayer's US Supreme Court win mean for the thousands of Roundup lawsuits?
Bayer shares soar over 18% after U.S. Supreme Court curbs Roundup lawsuits
US Supreme Court scales back Roundup cancer suits in win for Bayer (updated)
Bayer: US Supreme Court ruling should result in dismissal of current warning-based claims
Brief: Bayer AG - U.S. Supreme Court Decision Is Good For Science, Farmers, And Industries
Bayer shares surge after U.S. Supreme Court rules in favour of company
US Supreme Court scales back Roundup cancer lawsuits
Bayer's $7.25 billion Roundup deal faces possible speed bump in state court (updated)
Bayer's $7.25 billion Roundup deal faces possible speed bump in state court
Europe must rethink medicine pricing or risk losing investments, pharma lobby chief says (updated)
Brief: Bayer And Iambic Collaborate To Advance Drug Discovery With AI